Software program that looks for the most effective drugs helps to personalize cancer treatments

byThe Spanish National Cancer Research CentreGraphical Abstract. Credit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad412Precision medicine seeks to adapt treatments to the char

Updated on: January 16,2024

Software program that looks for the most effective drugs helps to personalize cancer treatments

byThe Spanish National Cancer Research CentreGraphical Abstract. Credit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad412Precision medicine seeks to adapt treatments to the char

Updated on:January 16,2024

Researchers discover common markers of tumor hypoxia across 19 cancer types

by Ontario Institute for Cancer ResearchUnlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despit

Updated on: June 22,2024

Researchers discover common markers of tumor hypoxia across 19 cancer types

by Ontario Institute for Cancer ResearchUnlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despit

Updated on:June 22,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024

Research targets metformin as breast cancer prescription

by Louisiana State UniversityCredit: LSU HealthResearch conducted by Suresh Alahari, Ph.D., Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that met

Updated on: July 02,2024

Research targets metformin as breast cancer prescription

by Louisiana State UniversityCredit: LSU HealthResearch conducted by Suresh Alahari, Ph.D., Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that met

Updated on:July 02,2024

Addressing higher colon cancer rates in rural areas

by Pennsylvania State UniversityCredit: Pixabay/CC0 Public DomainFor health care professionals, it's maddening.The technology needed to stopcolorectal cancerbefore it turns deadly

Updated on: March 20,2024

Addressing higher colon cancer rates in rural areas

by Pennsylvania State UniversityCredit: Pixabay/CC0 Public DomainFor health care professionals, it's maddening.The technology needed to stopcolorectal cancerbefore it turns deadly

Updated on:March 20,2024

A simple blood test provides personalised therapy for cancer patients

by FreshscienceDr Arutha Kulasinghe. Credit: Queensland University of Technology (QUT)Researchers have developed a simple blood test that can select cancer patients where therapies that use the body&#

Updated on: May 23,2024

A simple blood test provides personalised therapy for cancer patients

by FreshscienceDr Arutha Kulasinghe. Credit: Queensland University of Technology (QUT)Researchers have developed a simple blood test that can select cancer patients where therapies that use the body&#

Updated on:May 23,2024

Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective

by Society of Nuclear Medicine and Molecular ImagingScans were done at 2, 24, 72, 120 and 168 hours after the administration of177Lu-DOTA-EB-TATE. The radiopharmaceutical cleared from the blood

Updated on: April 18,2024

Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective

by Society of Nuclear Medicine and Molecular ImagingScans were done at 2, 24, 72, 120 and 168 hours after the administration of177Lu-DOTA-EB-TATE. The radiopharmaceutical cleared from the blood

Updated on:April 18,2024

Increased mitochondria and lipid turnover reduces risk for liver cancer

by University of Chicago Medical CenterLoss of BNIP3 promotes HCC initiation and tumor growth. (A) Representative images of HCC tumors forming in the liver of Bnip3+/+and bnip3−/−mice

Updated on: February 23,2024

Increased mitochondria and lipid turnover reduces risk for liver cancer

by University of Chicago Medical CenterLoss of BNIP3 promotes HCC initiation and tumor growth. (A) Representative images of HCC tumors forming in the liver of Bnip3+/+and bnip3−/−mice

Updated on:February 23,2024

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr

Updated on: February 23,2024

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr

Updated on:February 23,2024

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Updated on: April 14,2024

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Updated on:April 14,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on: January 30,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on:January 30,2024

Study compares the incidence of neuroendocrine neoplasms in China and the US

by Cactus CommunicationsNeuroendocrine neoplasms (NENs) are rare characterized by variable biology and delayed diagnosis. Researchers from China have now found disparities in the burden of NENs across

Updated on: January 16,2024

Study compares the incidence of neuroendocrine neoplasms in China and the US

by Cactus CommunicationsNeuroendocrine neoplasms (NENs) are rare characterized by variable biology and delayed diagnosis. Researchers from China have now found disparities in the burden of NENs across

Updated on:January 16,2024